Haemonetics Shares Hit New 52-Week High: What's Happening?
I'm LongbridgeAI, I can summarize articles.Haemonetics Corp (NYSE: HAE) shares surged 16.01% to a new 52-week high of $104.72 following a significant commercial agreement with CSL Plasma Inc. The deal allows CSL to adopt Haemonetics’ NexSys PCS devices and Persona PLUS technology across its U.S. network on a non-exclusive basis without minimum purchase commitments. While Haemonetics did not adjust its fiscal 2027 guidance, BTIG analyst Marie Thibault raised the price target from $96 to $110, reiterating a Buy rating.
Shares of Haemonetics Corp (NYSE:HAE) are trading higher Tuesday afternoon following news of a significant commercial agreement.
- Haemonetics stock is challenging resistance. Why did HAE hit a new high?
Key Terms and Implementation
The Boston-based medical technology provider disclosed that it has executed a supply agreement with CSL Plasma Inc., enabling CSL to adopt Haemonetics’ NexSys PCS devices paired with Persona PLUS technology across its U.S. network.
Under the terms of the agreement finalized on Aug. 14, CSL Plasma may utilize the advanced devices and purchase related single-use disposables across its U.S. collection centers. The arrangement operates on a non-exclusive basis and contains no minimum purchase commitments. Haemonetics anticipates that CSL will transition a portion of its domestic locations to the platform.
However, the company refrained from adjusting its existing fiscal 2027 financial guidance. Management noted in an SEC filing that the precise scope and implementation schedule remain pending, with an official update on financial impacts slated for its second-quarter earnings call in November.
Following the announcement, BTIG analyst Marie Thibault reiterated a Buy rating on Haemonetics shares and raised the firm’s price target on the stock from $96 to $110.
HAE Shares Surge Tuesday Afternoon
HAE Price Action: Haemonetics shares were up 16.01% at $104.72 at the time of publication on Tuesday. The stock is trading at a new 52-week high, according to Benzinga Pro data.
Read Also: What's Going On With Cerebras Systems Stock Tuesday?
Image: Shutterstock